Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptorsMaxemiliano V. Vargas, David E. Olson, Lee E. Dunlap et al.|Science|2023Cited by 464
A non-hallucinogenic psychedelic analogue with therapeutic potentialLindsay P. Cameron, David E. Olson, Jack C. Taylor et al.|Nature|2020Cited by 461
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor AgonistAnders A. Jensen, Jesper L. Kristensen, John D. McCorvy et al.|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 62
Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonistsMartin Hansen, Jesper L. Kristensen, Shane Plunkett et al.|Bioorganic & Medicinal Chemistry|2014Cited by 35